Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
In the dental-related business, CAD/CAM-related products contributed to domestic sales. Overseas sales increased steadily in North America and Latin America excluding China, Europe, and Asia and Oceania excluding China, while foreign exchange fluctuations also had an impact. Operating income increased due to the effect of higher sales and other factors, while ordinary income increased due to the change from foreign exchange losses to foreign exchange gains and an increase in dividend income. A ¥1,124 million gain on sales of investment securities also contributed to the increase in net income.
Not applicable (no matters to report in the notes on the going concern assumption)
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥10,788 million (YoY +13.5%) |
| Operating profit | ¥1,942 million (YoY +30.0%) |
| Ordinary income | ¥2,074 million (YoY +39.7%) |
| Profit attributable to owners of the parent | ¥2,146 million (YoY +151.3%) |
| Net income per share | ¥60.28 |
| Equity ratio | End of the current fiscal period 82 / End of previous period 84.1 |
| Total assets | ¥62,354 million |
| Net assets | ¥51,222 million |
| Full-year earnings forecast | Net Sales ¥42,958 million (YoY +7.4%) / Operating profit ¥6,003 million (YoY +14.9%) / Ordinary income ¥5,890 million (YoY +0.5%) / Net income ¥4,756 million (YoY -2.7%) |
| Annual Dividend Forecast | ¥60 per share → ¥67 per share（+11.7%） |
| Segment revenue | Dental-related business ¥10,247 million (YoY +14.3%), Nail-related business ¥516 million (YoY -0.5%), Other Businesses ¥25 million (YoY +14.1%) |
| Segment profit | Dental-related business ¥2,004 million (YoY +30.5%), Nail-related business ¥-61 million, Other Businesses ¥-1 million |
| Regional sales | ¥4,620 million, ¥1,407 million, ¥2,315 million, ¥2,445 million |
| Depreciation and amortization | ¥322 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥1,124 million / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | Not applicable (no matters to report in the notes on the going concern assumption) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name SHOFU DENTAL MIDDLE EAST＆AFRICA FZCO / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | A resolution was passed on 9 July 2026 to absorb the consolidated subsidiary 松風バイオフィックス株式会社, with the transaction scheduled to take place on 1 October 2026. 松風 will be the surviving company, and 松風バイオフィックス株式会社 will be dissolved. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Held (対象者：Not disclosed) |
| Issued Shares at Period-End | 35,788,178 |
| Treasury Shares at Period-End | 127,537 |
| Factors Behind Changes in Business Performance | In the dental-related business, CAD/CAM-related products contributed to domestic sales. Overseas sales increased steadily in North America and Latin America excluding China, Europe, and Asia and Oceania excluding China, while foreign exchange fluctuations also had an impact. Operating income increased due to the effect of higher sales and other factors, while ordinary income increased due to the change from foreign exchange losses to foreign exchange gains and an increase in dividend income. A ¥1,124 million gain on sales of investment securities also contributed to the increase in net income. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased due to contributions from CAD/CAM-related products, higher overseas sales and foreign exchange fluctuations, while operating income increased mainly due to the effect of higher sales. The increase in ordinary income was primarily attributable to the change from foreign exchange losses to foreign exchange gains and an increase in dividend income. The main factor behind the increase in net income attributable to owners of the parent was the recognition of a ¥1,124 million gain on sales of investment securities.